+65.8% · 90d
$3.05
-0.14 (-4.39%)
After-Hours $3.05(+0.00)
News
(1)April 2026
MacroGenics seeks vote to boost incentive shares by 1.25 million
MGNXMACROGENICS INC
# 📄 What This Document Is 📜 This filing is an "Additional Materials" supplement (DEFA14A) to MacroGenics, Inc.'s formal Proxy Statement. Think of a Proxy Statement as the official document guiding shareholders on how to vote at the annual meeting. This supplement exists because the company needed
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%